4.7 Article

Identification of a Characteristic Copy Number Alteration Profile by High-Resolution Single Nucleotide Polymorphism Arrays Associated With Metastatic Sporadic Colorectal Cancer

Journal

CANCER
Volume 120, Issue 13, Pages 1948-1959

Publisher

WILEY
DOI: 10.1002/cncr.28681

Keywords

liver metastases; colorectal carcinoma; copy number change; single nucleotide polymorphism array

Categories

Funding

  1. Instituto de Salud Carlos III (ISCIII), Ministerio de Sanidad y Consumo, Madrid, Spain [PI12-02053-FIS]
  2. Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain [BIO-SA02-13]
  3. RTICC [RD12-0020-0035-FEDER, RD12-0036-0048-FEDER]
  4. Fundacion Memoria de Don Samuel Solorzano Barruso, Salamanca, Spain
  5. Caja de Burgos (Obra Social), Burgos
  6. ISCIII, Ministerio de Ciencia e Innovacion, Madrid, Spain [CP05-00321]

Ask authors/readers for more resources

BACKGROUND: Metastatic dissemination is the most frequent cause of death in patients with sporadic colorectal cancer (sCRC). It is believed that the metastatic process is related at least in part to a specific background of genetic alterations accumulated in cells from primary tumors, and the ability to detect such alterations is critical for the identification of patients with sCRC who are at risk of developing metastases. METHODS: The authors used high-resolution, 500-K single nucleotide polymorphism arrays to identify copy number alteration profiles present at diagnosis in primary tumors from patients with metastatic (n = 23) versus nonmetastatic (n = 26) sCRC. RESULTS: The results revealed a characteristic pattern of copy number alterations in metastatic sCRC tumors that involved losses of 23 regions at chromosomes 1p, 17p, and 18q, together with gains of 35 regions at chromosomes 7 and 13q. CONCLUSIONS: In line with expectations, the copy number profile investigated involved multiple genes that were associated previously with sCRC (ie, SMAD2) and/or the metastatic process (ie, podocalyxin-like [PODXL]), and it also was associated with a poorer outcome. (C) 2014 American Cancer Society.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available